CYTOKINETICS INC — Director's Dealing 2013

Apr 8, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2013-04-01

Reporting Person: PARSHALL B LYNNE (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-04-01	Non-Qualified Stock Option (right to buy)	$1.14	A	28782	Acquired	2023-04-01	Common Stock (28782)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Option (right to buy)	$1.1	2023-02-07	Common Stock (50000)	50000	Direct

Footnotes

F1: This option shall vest and become exercisable as to 28,782 shares divided into equal monthly installments such that the option shall be 100% vested on January 1, 2014.

F2: This option was issued to the reporting person pursuant to the Cytokinetics 2004 Equity Incentive Plan in lieu of an annual retainer of $26,250.00.

F3: This option shall vest and become exercisable as to 50,000 shares divided into equal monthly installments such that the option shall be 100% vested on February 7, 2016.